Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04184349Phase 4Completed
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by UTHealth Houston. Primary endpoint: Total Narcotic Dose in Milligram Morphine Equivalents (MME) Per Kilogram at 48 hours. Started Oct 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04184349.